Cervical Cancer — Part Ii Screening, Diagnosis and Staging

SCREENING, DIAGNOSIS AND STAGING SCREENING 886 Papanicolaou (Pap) Test 886 Pap Smear Classification System 887 Problems Associated with the Pap Smear Test 887 Cytyc 888 AutoCyte 889 Morphometrix Technologies 889 Automated Analysis of Pap Smears 889 AutoCyte 889 Morphometrix Technologies 890 NeoPath 890 Neuromedical Systems 891 Cost and Reimbursement Issues Pertaining to Automated Screening 892 Other Products/Techniques 894 AccuMed International 894 diaDexus 894 Fourier transform infrared (FTIR) spectroscopy 894 NeoPath 894 Human Papillomavirus (HPV) Screening 894 DNA amplification 896 Digene 896 Serology 897 Other Approaches 897 Cytokine production 897 p53 protein polymorphisms 898 HIV Screening 898 Novel Markers 898 Nuclear Matrix Proteins 898 Telomerase 898 Cervicography 899 National Testing Laboratories 899 Speculoscopy 899 Trylon 900 Polarprobe 900 DIAGNOSIS AND STAGING 900 Colposcopy 900 DenVu 900 Invasive Procedures/Biopsy 900 Endocervical Curettage 900 Lymph Node Biopsy 901 Para-aortic lymph node biopsy 901 Pelvic lymph node (LN) dissection 901 Noninvasive Imaging 901 Magnetic Resonance (MR) Imaging 902 Other Imaging Modalities 902 Optical coherence tomography 902 PET-FDG 902